Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.
about
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 studyDiscrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer.
P2860
Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@ast
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@en
type
label
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@ast
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@en
prefLabel
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@ast
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@en
P2093
P356
P1476
Phase II study of oxaliplatin ...... fractory to fluoropyrimidines.
@en
P2093
Atsushi Ohtsu
Ichinosuke Hyodo
Kazuhiko Nakagawa
Kiyohiko Hatake
Kuniaki Shirao
Narikazu Boku
Takao Tamura
Yoshinori Miyata
Yusuke Tanigawara
P304
P356
10.1093/JJCO/HYM069
P577
2007-06-01T00:00:00Z